메뉴 건너뛰기




Volumn 12, Issue 3, 2009, Pages 153-157

Efficacy of sequential methotrexate and 5-fluorouracil (MTX/5FU) in improving oral intake in patients with advanced gastric cancer with severe peritoneal dissemination

Author keywords

Gastric cancer; Oral intake; Peritoneal dissemination; Sequential MTX 5FU therapy

Indexed keywords

ACETAZOLAMIDE; BICARBONATE; FLUOROURACIL; FOLINIC ACID; METHOTREXATE;

EID: 73449132552     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-009-0517-8     Document Type: Article
Times cited : (26)

References (11)
  • 1
    • 0011812049 scopus 로고    scopus 로고
    • Statistics and Information Department, Minister's Secretariat, Ministry of Health, Labour and Welfare Tokyo: Ministry of Health, Labour and Welfare
    • Statistics and Information Department, Minister's Secretariat, Ministry of Health, Labour and Welfare. Vital statistics of Japan (in Japanese). Tokyo: Ministry of Health, Labour and Welfare.
    • Vital Statistics of Japan (In Japanese)
  • 2
    • 0027217474 scopus 로고
    • Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer
    • 10.1002/1097-0142(19930701)72:1<37::AID-CNCR2820720109>3.0.CO;2-P 1:STN:280:DyaK3s3osVGqtQ%3D%3D 8508427
    • A.M. Murad F.F. Santiago A. Petroianu P.R. Rocha M.A. Rodrigues M. Rausch 1993 Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer Cancer 72 37 41 10.1002/1097-0142(19930701)72:1<37:: AID-CNCR2820720109>3.0.CO;2-P 1:STN:280:DyaK3s3osVGqtQ%3D%3D 8508427
    • (1993) Cancer , vol.72 , pp. 37-41
    • Murad, A.M.1    Santiago, F.F.2    Petroianu, A.3    Rocha, P.R.4    Rodrigues, M.A.5    Rausch, M.6
  • 3
    • 0028959887 scopus 로고
    • Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with nonresectable gastric cancer
    • 1:STN:280:DyaK2M7os1ertg%3D%3D 7533517
    • S. Pyrhonen T. Kuitunen P. Nyandoto M. Kouri 1995 Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with nonresectable gastric cancer Br J Cancer 71 587 591 1:STN:280:DyaK2M7os1ertg%3D%3D 7533517
    • (1995) Br J Cancer , vol.71 , pp. 587-591
    • Pyrhonen, S.1    Kuitunen, T.2    Nyandoto, P.3    Kouri, M.4
  • 4
    • 0028006253 scopus 로고
    • Initial or delayed chemotherapy with best supportive care in advanced gastric cancer
    • 1:STN:280:DyaK2c3kt1KrsA%3D%3D 8186165
    • B. Glimelius K. Hoffman U. Haglund O. Nyrén P.O. Sjödén 1994 Initial or delayed chemotherapy with best supportive care in advanced gastric cancer Ann Oncol 5 189 190 1:STN:280: DyaK2c3kt1KrsA%3D%3D 8186165
    • (1994) Ann Oncol , vol.5 , pp. 189-190
    • Glimelius, B.1    Hoffman, K.2    Haglund, U.3    Nyrén, O.4    Sjödén, P.O.5
  • 5
    • 35748972266 scopus 로고    scopus 로고
    • Randomized phase III study of 5-fluorouracil (5-FU) alone versus combination of irinotecan and cisplatin (CP) versus S-1 alone in advanced gastric cancer (JCOG9912)
    • (June 20 Supplement): LBA4513
    • Boku N, Yamamoto S, Shirao K, Doi T, Sawaki A, Koizumi W, et al. Randomized phase III study of 5-fluorouracil (5-FU) alone versus combination of irinotecan and cisplatin (CP) versus S-1 alone in advanced gastric cancer (JCOG9912). J Clin Oncol 2007 ASCO Annual Meeting Proceedings Part I;25:18S (June 20 Supplement): LBA4513.
    • J Clin Oncol 2007 ASCO Annual Meeting Proceedings Part i , vol.25
    • Boku, N.1    Yamamoto, S.2    Shirao, K.3    Doi, T.4    Sawaki, A.5    Koizumi, W.6
  • 6
    • 40749153540 scopus 로고    scopus 로고
    • S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): A phase III trial
    • 10.1016/S1470-2045(08)70035-4 1:CAS:528:DC%2BD1cXivVaqtb4%3D 18282805
    • W. Koizumi H. Narahara T. Hara A. Takagane T. Akiya M. Takagi, et al. 2008 S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial Lancet Oncol 9 215 221 10.1016/S1470-2045(08)70035-4 1:CAS:528:DC%2BD1cXivVaqtb4%3D 18282805
    • (2008) Lancet Oncol , vol.9 , pp. 215-221
    • Koizumi, W.1    Narahara, H.2    Hara, T.3    Takagane, A.4    Akiya, T.5    Takagi, M.6
  • 8
    • 6044256382 scopus 로고    scopus 로고
    • Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: A report from the gastrointestinal oncology study group of the Japan Clinical Oncology Group, JCOG 9603 trial
    • DOI 10.1093/jjco/hyh063
    • T. Yamao Y. Shimada K. Shirao A. Ohtsu N. Ikeda I. Hyodo, et al. 2004 Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trail Jpn J Clin Oncol 34 316 322 10.1093/jjco/hyh063 15333683 (Pubitemid 43118050)
    • (2004) Japanese Journal of Clinical Oncology , vol.34 , Issue.6 , pp. 316-322
    • Yamao, T.1    Shimada, Y.2    Shirao, K.3    Ohtsu, A.4    Ikeda, N.5    Hyodo, I.6    Saito, H.7    Iwase, H.8    Tsuji, Y.9    Tamura, T.10    Yamamoto, S.11    Yoshida, S.12
  • 9
    • 18244385013 scopus 로고    scopus 로고
    • Sequential methotrexate and 5-fluorouracil therapy for gastric cancer patients with peritoneal dissemination: A retrospective study
    • DOI 10.1007/s10120-001-8012-x
    • M. Tahara A. Ohtsu N. Boku F. Nagashima M. Myto Y. Sano, et al. 2001 Sequential methotrexate and 5-fluorouracil therapy for gastric cancer patients with peritoneal dissemination: a retrospective study Gastric Cancer 4 212 218 10.1007/s10120-001-8012-x 1:CAS:528:DC%2BD38XislCksbc%3D 11846065 (Pubitemid 34194980)
    • (2001) Gastric Cancer , vol.4 , Issue.4 , pp. 212-218
    • Tahara, M.1    Ohtsu, A.2    Boku, N.3    Nagashima, F.4    Muto, M.5    Sano, Y.6    Yoshida, M.7    Mera, K.8    Hironaka, S.-I.9    Tajiri, H.10    Yoshida, S.11
  • 10
    • 15944398713 scopus 로고    scopus 로고
    • Japanese translation of common terminology criteria for adverse events (CTCAE), and instructions and guidelines
    • Anonymous
    • Anonymous. Japanese translation of common terminology criteria for adverse events (CTCAE), and instructions and guidelines. Int J Clin Oncol 2004;9:1-82.
    • (2004) Int J Clin Oncol , vol.9 , pp. 1-82
  • 11
    • 0034942847 scopus 로고    scopus 로고
    • Japanese classification of gastric carcinoma - 2nd english edition - Response assessment of chemotherapy and radiotherapy for gastric carcinoma: Clinical criteria
    • DOI 10.1007/s101200100009
    • Japanese Gastric Cancer Association. 2001 Japanese Classification of Gastric Carcinoma - 2nd English edition - Response assessment of chemotherapy and radiotherapy for gastric carcinoma: clinical criteria Gastric Cancer 4 1 8 10.1007/s101200100009 (Pubitemid 32625928)
    • (2001) Gastric Cancer , vol.4 , Issue.1 , pp. 1-8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.